Post-discharge Malaria Chemoprevention(PMC) Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This study evaluates the efficacy and safety of 3 months of malaria chemoprevention post-discharge using dihydroartemisinin piperaquine (DHA-P) in children under 5 years of age admitted with severe anemia. One half will receive monthly DHA-P and the other half placebo.
Epistemonikos ID: 77c8dfea6351c1b128f6656f80fe323bb739d44c
First added on: May 12, 2024